1H magnetic resonance spectroscopy of prostate cancer: biomarkers for tumor characterization

Cancer Biomark. 2008;4(4-5):263-76. doi: 10.3233/cbm-2008-44-508.

Abstract

Proton Magnetic Resonance Spectroscopic Imaging (MRSI) permits a non-invasive assessment of metabolites in the prostate gland. This article reviews the assessment of choline-containing compounds, citrate, and polyamines as markers for prostate tumor detection and aggressiveness.

Publication types

  • Review

MeSH terms

  • Biomarkers, Tumor / analysis
  • Choline / analysis
  • Citrates / analysis
  • Humans
  • Magnetic Resonance Spectroscopy / methods*
  • Male
  • Polyamines / analysis
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / pathology

Substances

  • Biomarkers, Tumor
  • Citrates
  • Polyamines
  • Choline